Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FB894
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,137
Award facts
- Contract value 100% obligated
- $118,137.04 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $118,137.04 delivery order (Contract No. 4570301851) to AmerisourceBergen Drug Corp on December 16, 2025, with an ultimate completion date of the same day. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that supports global pharmaceutical supply to military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive IDC with the Defense Logistics Agency to supply critical pharmaceutical products and medical supplies to federal medical procurement needs, including those serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through its DLA contracts, the company provides an extensive portfolio of medications spanning multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic supplier within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FB894?
SPE2DU26FB894 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DU26FB894 worth?
The government has obligated $118,137 on SPE2DU26FB894.
Is contract SPE2DU26FB894 an order under another contract?
Yes. SPE2DU26FB894 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FB894 competed?
The extent of competition for SPE2DU26FB894 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award